The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Achieving high coverage in Rwanda’s national human papillomavirus vaccination programme
Open accessAbstract
PROBLEM: Virtually all women who have cervical cancer are infected with the human papillomavirus (HPV). Of the 275,000 women who die from cervical cancer every year, 88% live in developing countries. Two vaccines against the HPV have been approved. However, vaccine implementation in low-income countries tends to lag behind implementation in high-income countries by 15 to 20 years. APPROACH: In 2011, Rwanda's Ministry of Health partnered with Merck to offer the Gardasil HPV vaccine to all girls of appropriate age. The Ministry formed a "public-private community partnership" to ensure effective and equitable delivery. LOCAL SETTING: Thanks to a strong national focus on health systems strengthening, more than 90% of all Rwandan infants aged 12-23 months receive all basic immunizations recommended by the World Health Organization. RELEVANT CHANGES: In 2011, Rwanda's HPV vaccination programme achieved 93.23% coverage after the first three-dose course of vaccination among girls in grade six. This was made possible through school-based vaccination and community involvement in identifying girls absent from or not enrolled in school. A nationwide sensitization campaign preceded delivery of the first dose. LESSONS LEARNT: Through a series of innovative partnerships, Rwanda reduced the historical two-decade gap in vaccine introduction between high- and low-income countries to just five years. High coverage rates were achieved due to a delivery strategy that built on Rwanda's strong vaccination system and human resources framework. Following the GAVI Alliance's decision to begin financing HPV vaccination, Rwanda's example should motivate other countries to explore universal HPV vaccine coverage, although implementation must be tailored to the local context.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Home visits: a strategy to improve newborn survival - Authors' reply
(2008) · Americanae (AECID Library) · doi:10.1016/s0140 · Cited by 22,524
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,293
Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis
Forouzanfar, M. H., Foreman, K. J., Delossantos, A. M., Lozano, R., Lopez, A. D., Murray, C. J. L., & Naghavi, M. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61351-2 · Cited by 1,009
The global value of vaccination
Ehreth, J. (2003) · Vaccine · doi:10.1016/s0264-410x(02)00623-0 · Cited by 408
Introducing HPV Vaccine in Developing Countries — Key Challenges and Issues
Agosti, J. M., & Goldie, S. J. (2007) · New England Journal of Medicine · doi:10.1056/nejmp078053 · Cited by 350
LaMontagne, D. S., Barge, S., Le, N. T., Mugisha, E., Penny, M., Gandhi, S., Janmohamed, A., Kumakech, E., Mosqueira, N. R., Nguyen, N. Q., et al. (2011) · Bulletin of the World Health Organization · doi:10.2471/blt.11.08986 · Cited by 271
Rwanda Demographic and Health Survey 2005.
Haub, C., Barjot, P., Graesslin, O., Cohen, D. A., Vaillant, P., Clerson, P., Jarząbek, G., Pawlaczyk, M., Friebe, Z., de Souza, J. M., et al. (2006) · Gynécologie Obstétrique & Fertilité · Cited by 148
Human papillomavirus in a necessary cause of invasive cervical cancer worldwide
(1999) · Pure Amsterdam UMC · doi:10.1002/(sici)1096-9896(199909)189:1 · Cited by 140
Price, J., Leslie, J., Welsh, M., & Binagwaho, A. (2009) · AIDS Care · doi:10.1080/09540120802310957 · Cited by 82
Self-citationHargreaves, J., Greenwood, B. M., Clift, C., Goel, A., Roemer-Mahler, A., Smith, J., & Heymann, D. L. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60687-9 · Cited by 26
Cited by
Bruni, L., Saura-Lázaro, A., Montoliu, A., Brotons, M., Alemany, L., Diallo, M. S., Afsar, O. Z., LaMontagne, D. S., Mosina, L., Contreras, M., et al. (2021) · Preventive Medicine · doi:10.1016/j.ypmed.2020.106399 · Cited by 758
Human Papillomavirus Vaccine Introduction – The First Five Years
Markowitz, L. E., Tsu, V., Deeks, S. L., Cubie, H., Wang, S. A., Vicari, A. S., & Brotherton, J. M. L. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.05.039 · Cited by 364
Public–private partnerships (ppp s) in global health: the good, the bad and the ugly
Ruckert, A., & Labonté, R. (2014) · Third World Quarterly · doi:10.1080/01436597.2014.970870 · Cited by 164
Access and attitudes to HPV vaccination amongst hard-to-reach populations in Kenya
Watson-Jones, D., Mugo, N., Lees, S., Mathai, M., Vusha, S., Ndirangu, G., & Ross, D. A. (2015) · PLOS ONE · doi:10.1371/journal.pone.0123701 · Cited by 57
Metadata
- Authors
- Binagwaho, A., Wagner, C., Gatera, M., Karema, C., Nutt, C., & Ngaboa, F.
- Venue
- Bulletin of the World Health Organization
- Publisher
- WHO Press
- Published
- 2012-08-01
- Volume
- 90
- Issue
- 8
- Pages
- 623-628
- ISSN
- 0042-9686 (ISSN-L)
- OpenAlex
- W2034011038
- Cited by
- 275
- References
- 10
- FWCI
- 17.23
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.